Eli Lilly And Company Stock Signal: Did Earnings Justify The Rally?
A massive earnings beat sent shares rallying, but the latest GLP-1 treatment underperformed, while long-term debt is rising and profit margins are shrinking.
Dividends By The Numbers In November 2025
October 2025 broke an eight-month-long losing streak for dividend paying stocks in the U.S. stock market.
